| Acetaminophen-Hydrocodone Bitartrate Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Acetaminophen-Hydrocodone Bitartrate 500 mg-7.5 mg | tablet | oral | 1.0 each | OTC |
| Acetaminophen-Hydrocodone Bitartrate 500 mg-7.5 mg | tablet | oral | 1.0 each | OTC |
| Acetaminophen-Hydrocodone Bitartrate 500 mg-5 mg | tablet | oral | 1.0 each | OTC |
| Acetaminophen-Hydrocodone Bitartrate 500 mg-2.5 mg | tablet | oral | 1.0 each | OTC |
| Acetaminophen-Hydrocodone Bitartrate 750 mg-7.5 mg | tablet | oral | 1.0 each | OTC |
| Acetaminophen-Hydrocodone Bitartrate 650 mg-10 mg | tablet | oral | 1.0 each | OTC |
| Acetaminophen-Hydrocodone Bitartrate 650 mg-10 mg | tablet | oral | 1.0 each | OTC |
| Acetaminophen-Hydrocodone Bitartrate 325 mg-10 mg | tablet | oral | 1.0 each | OTC |
| Acetaminophen-Hydrocodone Bitartrate 660 mg-10 mg | tablet | oral | 1.0 each | OTC |
| Acetaminophen-Hydrocodone Bitartrate 500 mg-7.5 mg/15 mL | elixir | oral | 15.0 milliliter(s) | OTC |
Ranbaxy receives US FDA approval to manufacture and market ... - PipelineReview.com (press release)
“Hydrocodone Bitartrate and Acetaminophen Tablets are indicated for the relief of moderate to moderately severe pain and Ranbaxy is pleased to receive final ...
Tue Aug 21 02:26:43 -0400 2007
India's Ranbaxy Lab says gets FDA approval for pain relief drugs - CNNMoney.com
Annual sales for Hydrocodone Bitartrate and Acetaminophen tablets in 2006 was 390.6 mln usd, Ranbaxy said in a statement to the Bombay (OTCBB:BBAO) Stock ...
Mon Aug 20 03:16:59 -0400 2007
hydrocodone bitartrate
acetaminophen - An acetanilide with analgesic and antipyretic activity. Although the exact mechanism through which acetaminophen exert its effects has yet to be fully determined, this agent probably acts by inhibiting prostaglandin synthesis in the central nervous system (CNS). Inhibition of prostaglandin synthesis in the CNS results in elevation of the pain threshold and lowering of the thermal set point in the hypothalamus.